Neurobiology of depression -- Selective serotonin reuptake inhibitors (SSRIS) and serotonin norepinephrine reuptake inhibitors (SNRIS) -- Norepinephrine and dopamine reuptake inhibitors (NDRIS) and selective norepinephrine reuptake inhibitors (NRIS) -- Alpha 2 antagonists as serotonin and norepinephrine -- Monoamine oxidase inhibitors (MAOIS) and tricyclic antidepressants (TCAS) -- Building a treatment plan with novel treatment and augmentation options for depression -- Depression in women : treating symptoms throughout the life span -- Pharmacokinetics and algorithms to treat depression
Notes
Approved for a maximum of 3.0 AMA PRA Category 1 credits
